PharmaShots Weekly Snapshots (December 27- 31, 2021)
Published: Dec 31, 2021 | Tags: Immunovant, P-III Trial, Batoclimab, Myasthenia Gravis
Published: Dec 31, 2021 | Tags: Lexicon, NDA, Sotagliflozin, Heart Failure, Type 2 Diabetes
Bharat Biotech Reports Results of Covaxin (BBV152) in P-II/III Trial for the Treatment of COVID-19
Published: Dec 31, 2021 | Tags: Ocugen, Bharat Biotech, Covaxin, BBV152, P-II/III Trial, COVID-19
Published: Dec 31, 2021 | Tags: Xeris, Recorlev, levoketoconazole, US, FDA, Approval, Endogenous Hypercortisolemia, Cushing’s Syndrome
Published: Dec 31, 2021 | Tags: Madrigal, P-III, MAESTRO-NAFLD-1 Trial, Resmetirom, Non-Alcoholic Steatohepatitis
Published: Dec 31, 2021 | Tags: Jazz, P-II, Clinical Trial, JZP150, Post-Traumatic Stress Disorder
Bio-Thera Initiates P-I Clinical Trials of BAT6026 for the Treatment of Advanced Solid Tumor
Published: Dec 30, 2021 | Tags: Bio-Thera, Initiates, P-I, Clinical Trials, BAT6026, Cancer
Published: Dec 30, 2021 | Tags: Cantargia, Nadunolimab, P-I/IIa, CANFOUR Trial, Pancreatic Cancer
Published: Dec 30, 2021 | Tags: Siemens Healthineers, CLINITEST, COVID-19, Antigen Test, US, FDA, EUA, COVID-19
Published: Dec 30, 2021 | Tags: Antengene, P-Ib/II, REACH Study, ATG-016, Advanced Solid Tumors
Published: Dec 30, 2021 | Tags: Janssen, BLA, US, FDA, Approval, Teclistamab, Multiple Myeloma
Amylyx Reports US FDA Acceptance of NDA and Priority Review for AMX0035 to Treat ALS
Published: Dec 30, 2021 | Tags: Amylyx, US, FDA, Priority Review, NDA, AMX0035, ALS
Celularity’s CYNK-001 Receives the US FDA’s Fast Track Designation for the Treatment of AML
Published: Dec 29, 2021 | Tags: Celularity, CYNK-001, US, FDA, Fast Track Designation, AML
Published: Dec 29, 2021 | Tags: Hansa Biopharma, ConfIdeS Trial, Imlifidase, Kidney Transplant
Sorrento Reports Results of COVISTIX COVID-19 Test to Detects Omicron Variant
Published: Dec 29, 2021 | Tags: Sorrento, COVISTIX, COVID-19 Test, Omicron Variant
Palatin Reports the Initiation of P-III (MELODY-1) Trial for PL9643 to Treat Dry Eye Disease
Published: Dec 29, 2021 | Tags: Palatin, P-III, MELODY-1 Trial, PL9643, Dry Eye Disease
Kiniksa Reports Results of Mavrilimumab in P-III Trial for the Treatment of COVID-19-Related ARDS
Published: Dec 29, 2021 | Tags: Kiniksa, Mavrilimumab, P-III, Trial, COVID-19-Related ARDS
Daiichi Sankyo Reports Submission of NDA to MHLW for Valemetostat to Treat T-Cell Leukemia/Lymphoma
Published: Dec 29, 2021 | Tags: Daiichi Sankyo, NDA, MHLW, Valemetostat, T-Cell Leukemia/Lymphoma
LEO Pharma’s Adbry (tralokinumab) Receives US FDA’s Approval for the Treatment of Atopic Dermatitis
Published: Dec 28, 2021 | Tags: LEO Pharma, Adbry, tralokinumab, US, FDA, Approval, Atopic Dermatitis
Published: Dec 28, 2021 | Tags: BridgeBio Pharma, AG10, acoramidis, P-III, ATTRibute-CM Study, Transthyretin Amyloidosis
Published: Dec 28, 2021 | Tags: I-Mab, TJ271, enoblituzumab, Keytruda, pembrolizumab, NMPA, IND, Approval, P-II, Clinical Trial, Solid Tumors
Published: Dec 28, 2021 | Tags: Merck, Eisai, Keytruda, pembrolizumab, Lenvima, Lenvatinib, MHLW, Approval, Endometrial Carcinoma
Published: Dec 28, 2021 | Tags: Shionogi, Susmed, Digital Therapeutic App, Insomnia
Published: Dec 28, 2021 | Tags: ITM, Grand Pharma, Oncological, Radiopharmaceutical Therapies, Greater China
Published: Dec 27, 2021 | Tags: Boehringer Ingelheim, Spesolimab, P-II, Effisayil 1 Trial, Generalized Pustular Psoriasis, NEJM
Published: Dec 27, 2021 | Tags: Daiichi Sankyo, P-III, DESTINY-Lung04 Trial, Enhertu, trastuzumab deruxtecan, HER2 Mutant Metastatic NSCLC
Merck and Ridgeback’s Molnupiravir Receive MHLW’s Approval for the Treatment of COVID-19
Published: Dec 27, 2021 | Tags: Merck, Ridgeback, Molnupiravir, MHLW, Approval, COVID-19
Published: Dec 27, 2021 | Tags: Innovent, NMPA, sNDA, Tyvyt, sintilimab, Byvasda, biosimilar, bevacizumab, EGFR-Mutated, Non-squamous NSCLC
Quidel to Acquire Ortho Clinical Diagnostics for ~$6.0B
Published: Dec 27, 2021 | Tags: Quidel, Acquire, Ortho Clinical Diagnostics, ~$6.0B
Published: Dec 27, 2021 | Tags: Aarvik Therapeutics, Research Collaboration, ArriVent Biopharma, Noval Cancer Therapeutic
Related Post: PharmaShots Weekly Snapshots (December 20 - 23, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com